The Effects of Ketone Ester Supplementation During a 5 Week Live High, Train Low Altitude Training Camp

NCT ID: NCT06596083

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-10

Study Completion Date

2024-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the effects of post-exercise and pre-sleep exogenous ketosis via oral ketone ester supplementation during a 5 week simulated altitude training camp.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Altitude training camps, where you train at sea level but live at altitude, have become a popular way for athletes to prepare for upcoming races or events. The main aim of such training camps is to benefit from the adaptations following prolonged hypoxic exposure (increased EPO concentrations leading to an increase in oxygen carrying capacity in the blood). Recently, ketone bodies have been shown to cause similar adaptations. Therefore, this study aims to investigate whether the combination of exogenous ketosis and an altitude training camp is more beneficial compared to an altitude training camp on its own.

Participants will follow a 5 week simulated altitude training camp where they spend 75 hours per week at altitude (2000-3000 meters), while taking ketone or placebo supplements after every training sessions and before going to sleep. During these 5 weeks, they will adhere to a prescribed training plan, consisting of 5 to 7 training sessions per week. Before, after and 1 week after the training camp, their exercise performance, EPO concentrations, hemoglobin mass and VO2max will be tested.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoxia Exogenous Ketosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will go through the entire 5 week training camp and 1 week follow up while taking either ketone ester supplements (KE) or an isocaloric placebo (CON).
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators
Participants and investigators are blinded from the experimental condition (KE or CON). Supplements are provided in non transparent tubes and the control supplement is identical in taste and viscosity to the ketone supplement.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo Comparator

Training intervention: 5 weeks of live high, train low followed by an additional 1 week of reduced training (to simulate preparation for an upcoming event or race) Dietary intervention: placebo supplement

Group Type PLACEBO_COMPARATOR

Placebo supplement

Intervention Type DIETARY_SUPPLEMENT

oral supplement containing: 16.4 grams of medium chained triglycerides, 1mM or sucrose octaacetate and water

Experimental group

Training intervention: 5 weeks of live high, train low followed by an additional 1 week of reduced training (to simulate preparation for an upcoming event or race) Dietary intervention: Ketone ester supplement

Group Type EXPERIMENTAL

Ketone ester supplement

Intervention Type DIETARY_SUPPLEMENT

Oral supplement containing: 25 grams of pure (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate ketone monoester drink

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo supplement

oral supplement containing: 16.4 grams of medium chained triglycerides, 1mM or sucrose octaacetate and water

Intervention Type DIETARY_SUPPLEMENT

Ketone ester supplement

Oral supplement containing: 25 grams of pure (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate ketone monoester drink

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Physically fit and regularly involved in physical activity (2-5h per week)
* Good health status confirmed by a medical screening
* Non-smoking

Exclusion Criteria

* Any kind of injury/pathology that is a contra-indication to perform high-intensity exercise
* Any kind of injury/pathology that is a contra-indication for exposure to hypoxia
* Ongoing pregnancy or breastfeeding
* intake of any medication or nutritional supplement that is proven to affect exercise performance during the last month prior to the start of the study
* Involvement in elite athletic training at a semi-professional or professional level
* Exposure to altitudes higher than 1500 m during the 3 months prior to the start of the study
* Blood ferritin levels below 30 ng/mL
* Current participation in another research trial
* Any other argument to believe that the subject is unlikely to succesfully complete the full study protocol
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chiel Poffé

postdoctoral researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chiel Poffé

Role: PRINCIPAL_INVESTIGATOR

KU Leuven

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KU Leuven

Leuven, Vlaams-Brabant, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wout Lauriks

Role: CONTACT

+32474360778

Chiel Poffé

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chiel Poffé

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S67562

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.